• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Endosulfine-alpha 抑制膜诱导的 α-突触核蛋白聚集,并防止 α-突触核蛋白神经毒性。

Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.

Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA.

出版信息

Acta Neuropathol Commun. 2017 Jan 10;5(1):3. doi: 10.1186/s40478-016-0403-7.

DOI:10.1186/s40478-016-0403-7
PMID:28069058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5223451/
Abstract

Neuropathological and genetic findings suggest that the presynaptic protein α-synuclein (aSyn) is involved in the pathogenesis of synucleinopathy disorders, including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy. Evidence suggests that the self-assembly of aSyn conformers bound to phospholipid membranes in an aggregation-prone state plays a key role in aSyn neurotoxicity. Accordingly, we hypothesized that protein binding partners of lipid-associated aSyn could inhibit the formation of toxic aSyn oligomers at membrane surfaces. To address this hypothesis, we characterized the protein endosulfine-alpha (ENSA), previously shown to interact selectively with membrane-bound aSyn, in terms of its effects on the membrane-induced aggregation and neurotoxicity of two familial aSyn mutants, A30P and G51D. We found that wild-type ENSA, but not the non-aSyn-binding S109E variant, interfered with membrane-induced aSyn self-assembly, aSyn-mediated vesicle disruption and aSyn neurotoxicity. Immunoblotting analyses revealed that ENSA was down-regulated in the brains of synucleinopathy patients versus non-diseased individuals. Collectively, these results suggest that ENSA can alleviate neurotoxic effects of membrane-bound aSyn via an apparent chaperone-like activity at the membrane surface, and a decrease in ENSA expression may contribute to aSyn neuropathology in synucleinopathy disorders. More generally, our findings suggest that promoting interactions between lipid-bound, amyloidogenic proteins and their binding partners is a viable strategy to alleviate cytotoxicity in a range of protein misfolding disorders.

摘要

神经病理学和遗传学研究发现,突触前蛋白α-突触核蛋白(aSyn)可能与包括帕金森病(PD)、路易体痴呆(DLB)和多系统萎缩在内的多种突触核蛋白病的发病机制有关。有证据表明,与磷脂膜结合的 aSyn 构象体在易于聚集的状态下自组装,在 aSyn 神经毒性中发挥关键作用。因此,我们假设与脂相关的 aSyn 的蛋白结合伴侣可能会抑制膜表面有毒的 aSyn 寡聚物的形成。为了验证这一假说,我们对先前显示与膜结合的 aSyn 选择性相互作用的蛋白内磺素-α(ENSA)进行了研究,评估了其对两种家族性 aSyn 突变体 A30P 和 G51D 的膜诱导聚集和神经毒性的影响。结果发现,野生型 ENSA,但不是非 aSyn 结合的 S109E 变体,干扰了膜诱导的 aSyn 自组装、aSyn 介导的囊泡破坏和 aSyn 神经毒性。免疫印迹分析显示,与非疾病个体相比,突触核蛋白病患者的脑内 ENSA 表达下调。总的来说,这些结果表明,ENSA 可以通过在膜表面发挥明显的伴侣样活性来减轻膜结合的 aSyn 的神经毒性作用,而 ENSA 表达的降低可能导致突触核蛋白病中的 aSyn 神经病理学。更普遍的是,我们的研究结果表明,促进脂结合的、淀粉样蛋白的蛋白与其结合伴侣之间的相互作用是减轻多种蛋白错误折叠疾病细胞毒性的可行策略。

相似文献

1
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.Endosulfine-alpha 抑制膜诱导的 α-突触核蛋白聚集,并防止 α-突触核蛋白神经毒性。
Acta Neuropathol Commun. 2017 Jan 10;5(1):3. doi: 10.1186/s40478-016-0403-7.
2
Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.膜相互作用受损对α-突触核蛋白聚集和神经毒性的影响。
Neurobiol Dis. 2015 Jul;79:150-63. doi: 10.1016/j.nbd.2015.04.007. Epub 2015 Apr 27.
3
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.两个 C 末端序列变异决定了人源和鼠源α-突触核蛋白的神经毒性差异。
Mol Neurodegener. 2020 Sep 8;15(1):49. doi: 10.1186/s13024-020-00380-w.
4
Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.α-突触核蛋白聚集物隔离突触蛋白导致神经毒性,这种毒性被小肽所抑制。
PLoS One. 2018 Apr 2;13(4):e0195339. doi: 10.1371/journal.pone.0195339. eCollection 2018.
5
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.小分子α-突触核蛋白错误折叠抑制剂 NPT200-11 在帕金森病动物模型中产生多种益处。
Sci Rep. 2018 Nov 1;8(1):16165. doi: 10.1038/s41598-018-34490-9.
6
Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.帕金森病相关突变和 N 端乙酰化在 3,4-二羟苯乙酸诱导的α-突触核蛋白寡聚化中的作用。
ACS Chem Neurosci. 2019 Jan 16;10(1):690-703. doi: 10.1021/acschemneuro.8b00498. Epub 2018 Nov 5.
7
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.新型 A53E 阿尔法-突触核蛋白突变对其寡聚化和聚集的影响。
Acta Neuropathol Commun. 2016 Dec 9;4(1):128. doi: 10.1186/s40478-016-0402-8.
8
Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.通过单分子荧光光谱和 ThT 荧光测量检测到不同α-突触核蛋白突变体对脂质结合和聚集的影响。
ACS Chem Neurosci. 2019 Mar 20;10(3):1649-1659. doi: 10.1021/acschemneuro.8b00579. Epub 2019 Jan 16.
9
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.去甲替林通过增强单体构象重排抑制α-突触核蛋白聚集和神经毒性。
Neurobiol Dis. 2017 Oct;106:191-204. doi: 10.1016/j.nbd.2017.07.007. Epub 2017 Jul 12.
10
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.新发现的与帕金森病相关的突变G51D可减弱α-突触核蛋白在体外的聚集和膜结合,并增强其在细胞中的分泌和核定位。
Hum Mol Genet. 2014 Sep 1;23(17):4491-509. doi: 10.1093/hmg/ddu165. Epub 2014 Apr 11.

引用本文的文献

1
Co-expression-wide association studies link genetically regulated interactions with complex traits.共表达全基因组关联研究将基因调控的相互作用与复杂性状联系起来。
medRxiv. 2024 Dec 13:2024.10.02.24314813. doi: 10.1101/2024.10.02.24314813.
2
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies.寡聚物毒性、纤维毒性和纤维扩散在突触核蛋白病中的作用。
Cell Mol Life Sci. 2022 Mar 4;79(3):174. doi: 10.1007/s00018-022-04166-9.
3
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

本文引用的文献

1
Foldamer-mediated manipulation of a pre-amyloid toxin.折叠体介导的前淀粉样毒素操纵。
Nat Commun. 2016 Apr 25;7:11412. doi: 10.1038/ncomms11412.
2
Distinct Membrane Disruption Pathways Are Induced by 40-Residue β-Amyloid Peptides.由40个氨基酸残基的β-淀粉样肽诱导出不同的膜破坏途径。
J Biol Chem. 2016 Jun 3;291(23):12233-44. doi: 10.1074/jbc.M116.720656. Epub 2016 Apr 7.
3
Structural disorder of monomeric α-synuclein persists in mammalian cells.单体α-突触核蛋白的结构无序在哺乳动物细胞中持续存在。
α-突触核蛋白的翻译后修饰:对路易体疾病发病机制的影响
Front Aging Neurosci. 2021 Jun 25;13:690293. doi: 10.3389/fnagi.2021.690293. eCollection 2021.
4
AMPylation/Adenylylation of Alpha-synuclein by HYPE/FICD.HYPE/FICD对α-突触核蛋白的AMP化/腺苷酸化作用
Bio Protoc. 2020 Sep 20;10(18):e3760. doi: 10.21769/BioProtoc.3760.
5
Calcein Release Assay to Measure Membrane Permeabilization by Recombinant Alpha-Synuclein.用于测量重组α-突触核蛋白诱导的膜通透性的钙黄绿素释放测定法。
Bio Protoc. 2020 Jul 20;10(14). doi: 10.21769/bioprotoc.3690.
6
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.两个 C 末端序列变异决定了人源和鼠源α-突触核蛋白的神经毒性差异。
Mol Neurodegener. 2020 Sep 8;15(1):49. doi: 10.1186/s13024-020-00380-w.
7
Initiation and propagation of α-synuclein aggregation in the nervous system.α-突触核蛋白在神经系统中的聚集的起始和传播。
Mol Neurodegener. 2020 Mar 6;15(1):19. doi: 10.1186/s13024-020-00368-6.
8
Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.针对帕金森病治疗的α-突触核蛋白靶点:多管齐下的探索。
Biomolecules. 2020 Mar 3;10(3):391. doi: 10.3390/biom10030391.
9
Assembly of α-synuclein aggregates on phospholipid bilayers.α-突触核蛋白聚集体在磷脂双层上的组装。
Biochim Biophys Acta Proteins Proteom. 2019 Sep;1867(9):802-812. doi: 10.1016/j.bbapap.2019.06.006. Epub 2019 Jun 19.
10
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases.翻译后修饰对α-突触核蛋白在帕金森病发病机制中的作用
Front Neurosci. 2019 Apr 18;13:381. doi: 10.3389/fnins.2019.00381. eCollection 2019.
Nature. 2016 Feb 4;530(7588):45-50. doi: 10.1038/nature16531. Epub 2016 Jan 25.
4
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.胰岛淀粉样多肽:结构、功能与病理生理学
J Diabetes Res. 2016;2016:2798269. doi: 10.1155/2016/2798269. Epub 2015 Nov 15.
5
Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models.α-突触核蛋白突变的表型谱:来自患者和细胞模型的新见解
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S16-20. doi: 10.1016/j.parkreldis.2015.08.015. Epub 2015 Aug 18.
6
Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.膜相互作用受损对α-突触核蛋白聚集和神经毒性的影响。
Neurobiol Dis. 2015 Jul;79:150-63. doi: 10.1016/j.nbd.2015.04.007. Epub 2015 Apr 27.
7
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation.脂质囊泡通过刺激初级成核作用引发α-突触核蛋白聚集。
Nat Chem Biol. 2015 Mar;11(3):229-34. doi: 10.1038/nchembio.1750. Epub 2015 Feb 2.
8
In vitro study of α-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway.通过 cryo-EM 对 α-突触核蛋白原纤维的体外研究表明存在 Cu(2+)-依赖性聚集途径。
Biophys J. 2013 Jun 18;104(12):2706-13. doi: 10.1016/j.bpj.2013.04.050.
9
Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2.天然α-突触核蛋白通过与磷脂和突触小泡蛋白-2/囊泡相关膜蛋白2结合,诱导突触小泡模拟物聚集。
Elife. 2013 Apr 30;2:e00592. doi: 10.7554/eLife.00592.
10
G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.G51D α-突触核蛋白突变导致一种新型帕金森-锥体束综合征。
Ann Neurol. 2013 Apr;73(4):459-71. doi: 10.1002/ana.23894.